21 May 2013
Keywords: Amgen, Sensipar, Mimpara, Cardiovascular events, Dialysis patients, Ph III
Article | 11 June 2012
Amgen (Nasdaq: AMGN), the world’s largest independent biotech company, announced top-line results on Friday of the Phase III ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 June 2012
12 June 2012
20 May 2013
© 2013 thepharmaletter.com